Source: Indian Pharma Post

ABclonal: ABclonal Technology joins YCharOS advisory committee to tackle reproducibility crisis in biomedical research

Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Wu Zack

CEO Approval Rating

90/100

Read more